A new survey of UK radiologists finds that 100% of NHS trusts have now used pre-biopsy MRI, although variations persist in ...

Prostate cancers that are missed on multiparametric (mp)MRI are small and potentially not clinically significant, according to an analysis of data from the Prostate MR Imaging Study (PROMIS). "Our ...

Trends in prostate cancer mortality in the United States of America, by state and race, from 1999 to 2019: Estimates from the Centers for Disease Control WONDER database. Predicting the outcome of ...

Please provide your email address to receive an email when new articles are posted on . First-line biparametric MRI testing increased the number of biopsies and overdiagnoses vs. first-line PSA ...

Microultrasonography for prostate biopsy detected clinically significant cancer at rates comparable to MRI-guided approaches. Detection rates for clinically insignificant cancers did not differ among ...

As radiologic tumor size and PI-RADS version 2 score decreased, the degree to which pathologic tumor size is underestimated increased, investigators reported. Pathologic prostate tumor size is often ...

In patients with a high suspicion of prostate cancer as determined by molecular imaging, avoiding biopsy prior to radical prostatectomy appeared to be feasible, and "might represent a valid option in ...

A trial found no meaningful difference in detection of clinically significantly prostate cancer between multiparametric MRI-based and microultrasound-based biopsy techniques.

Researchers in the UK have demonstrated a new kind of ultrasound scan can diagnose prostate cancer with accuracy equal to costly and time-consuming magnetic resonance imaging (MRI). The findings offer ...